47 results
POS AM
ABVC
ABVC BioPharma Inc
25 Apr 24
Prospectus update (post-effective amendment)
2:38pm
to liabilities under the U.S. Foreign Corrupt Practices Act (“FCPA”) and Chinese anti-corruption law.
The Company is subject to the FCPA, and other laws … in mainland China and the U.S., during the process of which the Company may be exposed to corruption. Activities in Taiwan create the risk of unauthorized
424B4
ABVC
ABVC BioPharma Inc
5 Apr 24
Prospectus supplement with pricing info
2:47pm
the U.S. Foreign Corrupt Practices Act (“FCPA”) and Chinese anti-corruption law.
The Company is subject to the FCPA, and other laws that prohibit improper … ., during the process of which the Company may be exposed to corruption. Activities in Taiwan create the risk of unauthorized payments or offers
DEFA14A
ABVC
ABVC BioPharma Inc
25 Mar 24
Additional proxy soliciting materials
4:30pm
.
The Company may be exposed to liabilities under the U.S. Foreign Corrupt Practices Act (“FCPA”) and Chinese anti-corruption law.
The Company is subject … parties who may make sales in mainland China and the U.S., during the process of which the Company may be exposed to corruption. Activities in Taiwan create
424B4
np3suspwtq 9j2qe0
12 Jun 23
Prospectus supplement with pricing info
4:30pm
POS AM
k6y0w 4lz
26 Apr 23
Prospectus update (post-effective amendment)
2:08pm
POS AM
3yfdjgnpcg 8z6eu
26 Apr 23
Prospectus update (post-effective amendment)
1:29pm
424B4
9u8o8bwicju6o
11 Jul 22
Prospectus supplement with pricing info
4:01pm
424B3
odjk1
11 Jul 22
Prospectus supplement
4:00pm